Exou-induced vascular hyperpermeability and platelet activation in the course of experimental pseudomonas aeruginosa pneumosepsis

Shock

Volumn 33, Issue 3, 2010, Pages 315-321

  MacHado, Gloria Beatriz S ^a   De Assis, Maria Cristina ^a   Leão, Robson ^a   Saliba, Alessandra M ^a   Silva, Mauricio C A ^b   Suassuna, Jose H ^a   De Oliveira, Albanita V ^a   Plotkowski, Maria Cristina ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

P selectin expressing platelets; Platelet activation; Platelet derived microparticles; Pneumosepsis; Thromboxane A2; Thrombus formation; Vascular hyperpermeability

Indexed keywords

BACTERIAL TOXIN; CYTOTOXIN; EXOU CYTOTOXIN; PADGEM PROTEIN; PHOSPHOLIPASE A2; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; EXPERIMENTAL MODEL; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; KAPLAN MEIER METHOD; KIDNEY; LUNG INFECTION; MORTALITY; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEPSIS; SURVIVAL RATE; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

ANIMALS; BACTERIAL PROTEINS; CAPILLARY PERMEABILITY; CELL-DERIVED MICROPARTICLES; FEMALE; KIDNEY; MICE; P-SELECTIN; PLATELET ACTIVATION; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SHOCK, SEPTIC; THROMBOXANE A2;

EID: 77149151879     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181b2b0f4     Document Type: Article

References (38)

1. Vidal F, Mensa J, Almela M, Martinez JA, Marco F, Casals C, Gatell JM, Soriano E, Jimenez de Anta MT: Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 156:2121-2126, 1996.
2. Wolfgang MC, Kulasekara BR, Liang X, Boyd D, Wu K, Yang Q, Miyada CG, Lory S: Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100:8484-8489, 2003.
3. Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR: Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147:2659-2669, 2001. (Pubitemid 32976307)
4. Sato H, Frank DW: ExoU is a potent intracellular phospholipase. Mol Microbiol 53:1279-1290, 2004.
5. Saliba AM, Nascimento DO, Silva MC, Gayer CR, Raymond B, Coelho MG, Marques EA, Touqui L, Albano RM, Lopes UG, et al.: Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell Microbiol 7:1811-1822, 2005.
6. Plotkowski MC, Brandão BA, de Assis MC, Feliciano LF, Raymind B, Freitas C, Saliba AM, Zahm JM, Touqui L, Bozza PT: Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells. Microb Pathog 45:30-37, 2008.
7. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP: Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 104:743-750, 1999.
8. Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swanson BL, Spack EG, Wiener-Kronish JP: Therapeutic administration of anti-PcrV F(ab¶)(2) is sepsis associated with Pseudomonas aeruginosa. J Immunol 167:5880-5886, 2001.
9. Shaver CM, Hauser AR: Relative contribution of Pseudomonas aeruginosa ExoU, ExoS, ExoT to virulence in the lung. Infect Immun 72:6969-6977, 2004.
10. Berthelot P, Attree I, Plesiat P, Chabert J, de Bentzmann S, Pozzetto B, Grattard F, Groupe d'études des septicemias à Pseudomonas aeruginosa: Genotypic and phenotypic analysis of the type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J Infect Dis 188:512-518, 2003.
11. Schulert GS, Feltman H, Rabin SDP, Martin CG, Battle SE, Rello J, Hauser AR: Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 188:1695-1706, 2003.
12. Mammen EF: The haematological manifestations of sepsis. J Antimicrob Chemother 41(suppl A):17-24, 1998.
13. Levi M, Keller TT, van Gorp E, ten Cate H: Infection and inflammation and the coagulation system. Cardiovasc Res 60:26-39, 2003.
14. Ellis CG, Jagger J, Sharpe M: The microcirculation as a functional system. Crit Care 9(suppl 4):S3-S8, 2005.
15. Jonkam CC, Lange M, Traber DL, Maybauer DM, Maybauer MO, Bansal K, Hamahata A, Zhu Y, Esechie A, Traber LD, et al.: Cardiovascular collapse and vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis. Shock 32(6):621-625, 2009.
16. Plotkowski MC, Feliciano LFP, Machado GBS, Cunha LG Jr, Freitas C, Saliba AM, Assis MC: ExoU-induced procoagulant activity in Pseudomonas aeruginosaYinfected airway cells. Eur Respir J 32:1591-1598, 2008.
17. Michelson AD: Flow cytometry: a clinical test of platelet function. Blood 12:4925-4936, 1996.
18. Freyssinet JM: Cellular microparticles: what are they bad or good for? J Thromb Haemost 1:1655-1662, 2003.
19. Rogers DF, Boschetto P, Barnes PJ: Plasma exudation: correlation between Evans blue and radiolabeled albumin in guinea-pig airways in vivo. J Pharmacol Methods 21:309-315, 1989.
20. He X, Han B, Mura M, Lil L, Cypel M, Soderman A, Picha K, Yang J, Liu M: AntiYhuman tissue-factor antibody ameliorated intestinal ischemia reperfusionY induced acute lung injury in human tissue factor knock-in mice. PLoS ONE 3:e1527, 2008.
21. Nomura S, Ozaki Y, Ikeda Y: Function and role of microparticles in various clinical settings. Thromb Res 123:8-23, 2008.
22. Farand P, Hamel M, Lauzier F, Plante GE, Lesur O: Organ perfusion/ permeabilityYrelated effects of norepinephrine and vasopressin in sepsis. Can J Anaesth 53:934-946, 2006.
23. Czabanka M, Peter C, Martin E, Walther A: Microcirculatory endothelial dysfunction during endotoxemiaVinsights into pathophysiology, pathologic mechanisms and clinical relevance. Curr Vasc Pharmacol 5:266-275, 2007.
24. Reinhart K, Bayer O, Brunkhorst F, Meisner M: Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 30(suppl): S302-S312, 2002.
25. Bannerman DD, Goldblum SE: Direct effects of endotoxin on the endothe-lium: barrier function and injury. Lab Invest 79:1181-1199, 1999.
26. Sayner SL, Frank DW, King J, Chen H, VandeWaa J, Stevens T: Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY. Circ Res 95:196-203, 2004.
27. Hocke AC, Temmesfeld-Wollbrueck B, Schmeck B, Berger K, Frisch EM, Witzenrath M, Brell B, Suttorp N, Hippenstiel S: Perturbation of endothelial junction proteins by Staphylococcus aureus alpha-toxin: inhibition of endo-thelial gap formation by adrenomedullin. Histochem Cell Biol 126:305-316, 2006.
28. Saliba AM, de Assis MC, Nishi R, Raymond B, Marques Ede A, Lopes UG, Touqui L, Plotkowski MC: Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU. Microbes Infect 8:450-459, 2006.
29. Clawson CC, White JG: Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol 65:367-380, 1971.
30. Kuckleburg CJ, Sylte MJ, Inzana TJ, Corbeil LB, Darien BJ, Czuprynski CJ: Bovine platelets activated by Haemophilus somnus and its LOS induce apoptosis in bovine endothelial cells. Microb Pathog 38:23-32, 2005.
31. Mirlashari MR, Hagberg IA, Lyberg T: Platelet-platelet and platelet-leukocyte interactions induced by outer vesicles from N. meningitidis. Platelets 13: 91-99, 2002.
32. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P: Platelets express functional Toll-like receptor 4. Blood 106:2417-2423, 2005.
33. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW: Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107:637-641, 2006.
34. Bondanza A, Sabbadini MG, Pellegatta F, Zimmermann VS, Tincani A, Balestrieri G, Manfredi AA, Rovere P: Anti-beta2 glycoprotein I antibodies prevent the de-activation of platelets and sustain their phagocytic clearance. J Autoimmun 15:469-477, 2000.
35. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR: In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 93:11877-11882, 1996.
36. 2. FASEB J 46:133-138, 1987.
37. Boffa JJ, Just A, Coffman TM, Arendshorst WJ: Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. J Am Soc Nephrol 15:2358-2365, 2004.
38. Nieuwland R, Berckmans RJ, McGregor S, Boinq AN, Romijn FP, Westendorp RG, Hack CE, Sturk A: Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95:930-935, 2000.